These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25394162)

  • 21. Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related.
    Falasca K; Reale M; Ucciferri C; Di Nicola M; Di Martino G; D'Angelo C; Coladonato S; Vecchiet J
    AIDS Res Hum Retroviruses; 2017 Mar; 33(3):246-253. PubMed ID: 27615271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
    Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
    Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral function tests reveal differences in HIV-infected subjects with and without chronic HCV co-infection.
    Thiyagarajan A; Garvey LJ; Pflugrad H; Maruff P; Scullard G; Main J; Taylor-Robsinson S; Winston A
    Clin Microbiol Infect; 2010 Oct; 16(10):1579-84. PubMed ID: 20132257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.
    Nunes D; Fleming C; Offner G; Craven D; Fix O; Heeren T; Koziel MJ; Graham C; Tumilty S; Skolnik P; Stuver S; Horsburgh CR; Cotton D
    Am J Gastroenterol; 2010 Jun; 105(6):1346-53. PubMed ID: 20179698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of non-invasive models for liver fibrosis in chronic hepatitis B virus related liver disease patients in resource limited settings.
    Shrivastava R; Sen S; Banerji D; Praharaj AK; Chopra GS; Gill SS
    Indian J Pathol Microbiol; 2013; 56(3):196-9. PubMed ID: 24152493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
    Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH
    J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index.
    Trang T; Petersen JR; Snyder N
    Clin Chim Acta; 2008 Nov; 397(1-2):51-4. PubMed ID: 18692034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.
    Berenguer J; Fernandez-Rodríguez A; Jimenez-Sousa MA; Cosín J; Zarate P; Micheloud D; López JC; Miralles P; Catalán P; Resino S
    Cytokine; 2012 Jan; 57(1):25-9. PubMed ID: 22136974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive reserve and neuropsychological functioning in older HIV-infected people.
    Milanini B; Ciccarelli N; Fabbiani M; Limiti S; Grima P; Rossetti B; Visconti E; Tamburrini E; Cauda R; Di Giambenedetto S
    J Neurovirol; 2016 Oct; 22(5):575-583. PubMed ID: 26965299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.
    Parsons TD; Tucker KA; Hall CD; Robertson WT; Eron JJ; Fried MW; Robertson KR
    AIDS; 2006 Aug; 20(12):1591-5. PubMed ID: 16868439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study.
    Dominguez S; Ghosn J; Peytavin G; Guiguet M; Tubiana R; Valantin MA; Murphy R; Bricaire F; Benhamou Y; Katlama C
    J Antimicrob Chemother; 2010 Nov; 65(11):2445-9. PubMed ID: 20813809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
    Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
    J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
    AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.
    Grima P; Fabbiani M; Ciccarelli N; Tana M; Farina S; Colafigli M; Mondi A; Cauda R; Di Giambenedetto S
    J Infect; 2012 Nov; 65(5):439-46. PubMed ID: 22863903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
    Lin ZH; Xin YN; Dong QJ; Wang Q; Jiang XJ; Zhan SH; Sun Y; Xuan SY
    Hepatology; 2011 Mar; 53(3):726-36. PubMed ID: 21319189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls.
    Cohen S; Ter Stege JA; Geurtsen GJ; Scherpbier HJ; Kuijpers TW; Reiss P; Schmand B; Pajkrt D
    Clin Infect Dis; 2015 Apr; 60(7):1111-9. PubMed ID: 25516183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis.
    Fialho R; Pereira M; Bucur M; Fisher M; Whale R; Rusted J
    AIDS Care; 2015 Nov; ():. PubMed ID: 26542344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity.
    Gott C; Gates T; Dermody N; Brew BJ; Cysique LA
    PLoS One; 2017; 12(3):e0171887. PubMed ID: 28264037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.